Login
From:
U.S. Food and Drug Administration
(Uncensored)
subscribe
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
links
backlinks
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
